In that study, the authors documented increased mitochondrial biogenesis in ovarian cancer from an increase in the number of mitochondria along with increased PGC1α level, mitochondrial transcription factor (TFAM) level, and mitochondrial DNA (mtDNA) content. This evidence concerns the gene TFAM and ovarian cancer.